Adverse events in haematological malignancies
The Lancet Haematology in conversation with
English - June 12, 2018 07:00 - 12 minutes - 8.63 MBLife Sciences Science Education blood haemophilia haematology leukaemia Homepage Download Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed
Previous Episode: EPO blood doping and cycling: The Lancet Haematology: June 29, 2017
Next Episode: Predicting the risk of adenoviraemia
Lead author Gita Thanarajasingam joins The Lancet Haematology to discuss the new Commission on assessment and adverse event reporting in haematological malignancies.
Continue this conversation on social!
Follow us today at...
https://twitter.com/thelancet
https://instagram.com/thelancetgroup
https://facebook.com/thelancetmedicaljournal
https://linkedIn.com/company/the-lancet
https://youtube.com/thelancettv